PATENT CLAIM ANALYSIS

Application Number: 15872199
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "370000"]

Abstract:
The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.

Claim (Index 12):
The compound for use according to  claim 11 , wherein the compound is administered orally, topically, transdermally, parenterally, subcutaneously, intravenously, intramuscularly, intraperitoneally, by intranasal instillation, by intracavitary or intravesical instillation, intraocularly, intraarterially, intralesionally, or by application to mucous membranes.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 86.0
- Lexical Diversity: 1.53125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14049950', '14692597', '13676650', '13216927', '12981233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8537454251939566
- 35 USC 102 Novelty (BERT): 0.5702064506060348
- Combined Prediction Score: 0.8253915277351643
- Mean Citation Score: 529.1775359999998
- Max Citation Score: 609.86
- Similarity Product: 346.37795403838163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test